Daiichi Sankyo will use undiluted solutions provided by AstraZeneca to manufacture COVID-19 vaccines in Japan... Feb 10
COVAX, today announced that it had arrangements in place to access nearly two billion doses of COVID-19 vaccine candidates, on behalf of 190 participating ... Dec 19
The vaccine was co-invented by the University of Oxford and its spin-out company Vaccitech... Dec 12
Interim analysis showed vaccine is effective at preventing COVID-19, with no severe cases and no hospitalizations more than 21 days after first injection... Dec 09
AstraZeneca gears up for regulatory approvals... Nov 24
Clinical trials are also being conducted in the US, Japan, Russia, South Africa, Kenya and Latin America with planned trials in other European and Asian ... Nov 24
Positive high-level results from an interim analysis of clinical trials of AZD1222 in the UK and Brazil showed the vaccine was highly effective in ... Nov 23
All the participants must be 18-85 years old, not pregnant, in good general health, and have not been previously diagnosed with COVID-19 ... Nov 12
Clinical trials for the AstraZeneca Oxford coronavirus vaccine, AZD1222, have resumed across the world... Oct 24
AstraZeneca announced on Wednesday it had "voluntarily paused" its trial of the vaccine developed alongside Oxford University... Sep 14
Clinical trials for the AstraZeneca Oxford coronavirus vaccine, AZD1222, have resumed in the UK following confirmation by the MHRA that it was safe to do ... Sep 14
AstraZeneca, which is developing the drug alongside the University of Oxford, is a frontrunner in the global race for a Covid-19 vaccine.... Sep 09
AstraZeneca closer to COVID vaccine as 3rd phase trial starts... Sep 01
Catalent and Astrazeneca partners for the Covid vaccine manufacturing... Aug 26
A major deal registered to provide 400M doses of the COVID-19 vaccine to the EU ... Aug 19
Novavax at the top of vaccine development, starts several test facilities simultaneously ... Aug 18
Now Wockhardt also enters the Covid vaccine manufacturing business... Aug 03
Cobra Biologics signs supply agreement with AstraZeneca for manufacture of COVID-19 vaccine candidate... Jul 23
The vaccine did not prompt any serious side effects and elicited antibody and T-cell immune responses... Jul 21
Early-stage human trial data on a vaccine being developed by AstraZeneca and Oxford University will be published on July 20. ... Jul 17
Indigenous Indian COVID-19 vaccines in the global race to end the pandemic: Dr. TV Venkateswaran... Jul 06
Symbiosis and AstraZeneca sign supply agreement for sterile manufacture of COVID-19 vaccine for clinical trials ... Jun 25
IRBM’S ADVENT manufactures 13000 doses of the vaccine to be used in clinical trials by Oxford University ... May 30
AstraZeneca is partnering with the University of Oxford to develop and distribute a vaccine being trialed in the UK.... May 22
-Advertisements-
.jpeg)
Friday, August 07, 2026
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
